Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced an expanded Series A and new appointments to its executive leadership team, board of ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, and Ajinomoto Health & Nutrition North America, Inc. (AHN), a leader in amino acid science and cell culture ...

The hottest new programming language is English. Andrej Karpathy, OpenAI co-founder and former Tesla AI director, said this ...

Sionna Therapeutics targets cystic fibrosis with novel CFTR/NBD1 stabilization; key 2026 readouts and cash runway to 2028.

Babies born in the U.S. between July 2 and Dec. 31, 2026, will receive a "first-of-its-kind" commemorative Social Security card.

Python’s lead narrows again, C holds the runner-up spot, C++ returns to third, and SQL climbs back above R in June’s top 10 ...

FDA grants accelerated approval to Vera's Trutakna for IgA nephropathy, first dual BAFF/APRIL inhibitor. Competes with ...

Beauty's next frontier isn't a product, it's brain health, with science-backed rituals reshaping skincare and a wellness ...

A pre-wedding video showing Pune realtor Ketan Agarwal joyfully celebrating with his fiancée Siya Goyal and her parents has ...

Part 1 of this min-series established why CXL Type 3 memory expanders matter for capacity-bound workloads and where expander ...

Angela’s progress reflects the broader purpose of cancer rehabilitation at Levine Cancer: helping patients manage the ...

Researchers have uncovered a molecular “switch” that helps explain why exercise keeps ageing muscles healthy. By reducing ...